共 50 条
- [4] Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E250 - E250
- [5] The Early Result of Stereotactic Body Radiation Therapy Boost for High-Risk Localized Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S373 - S374
- [6] Favorable Biochemical Relapse Free Survival (BRFS) At 10 Years Following Stereotactic Body Radiation Therapy (SBRT) For Intermediate And High-Risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E899 - E900
- [7] Stereotactic Body Radiation Therapy for Low, Intermediate, and High-risk Prostate Cancer: Disease Control and Quality of Life [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S100 - S100
- [8] Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S361 - S361
- [9] Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer [J]. CANCER JOURNAL, 2020, 26 (01): : 38 - 42
- [10] Multicenter Assessment of Stereotactic Body Radiation Therapy (SBRT) Boost in Intermediate-Risk Prostate Cancer: Biochemical Failure and Toxicity [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E281 - E282